HeLa cells

HeLa cells
National Institutes of Health (NIH) · Public domain · source
Name	HeLa cells
Origin	Henrietta Lacks; Johns Hopkins Hospital
Species	Homo sapiens
Cell type	epithelial; adenocarcinoma
Established	1951
Notable for	first immortalized human cell line used in widespread research

HeLa cells HeLa cells are a continuously cultured human cell line derived from cervical cancer tissue taken from Henrietta Lacks in 1951 at Johns Hopkins Hospital. They became the first immortalized human cell line to be widely distributed, enabling experiments in laboratories at institutions such as Rockefeller University, Cold Spring Harbor Laboratory, Massachusetts Institute of Technology, University of Cambridge, and Stanford University. HeLa cultures accelerated work connected to vaccine development, cell biology, cancer research, and space biology, intersecting with programs like Polio vaccine trials and missions of NASA. The line’s provenance and use also sparked legal and ethical debates involving entities including NIH, Montgomery County (Maryland), and the Lacks family.

History and origin

HeLa originated from a biopsy taken from Henrietta Lacks while she was treated for cervical cancer at Johns Hopkins Hospital under physicians including Dr. George Gey and staff associated with the hospital's oncology services. The cells were cultured by Gey’s laboratory team at Johns Hopkins Hospital and propagated into laboratories such as Salk Institute and Wistar Institute. Samples were shared with researchers at institutions like Columbia University, University of Pennsylvania, Yale University, and University of Chicago. Public revelations about the cells’ origin intersected with reporting by outlets such as The New York Times and debates involving RAC (NIH) and later policy actions by bodies including National Institutes of Health.

Biological characteristics

HeLa cells are derived from an aggressive adenocarcinoma of the cervix and exhibit traits such as rapid proliferation, aneuploidy, and active telomerase expression similar to observations in studies at Cold Spring Harbor Laboratory and Salk Institute. Cytogenetic analyses at institutions including University of California, San Francisco have documented complex karyotypes, multiple chromosomal abnormalities, and integration of human papillomavirus DNA consistent with work on HPV by researchers at University of Wisconsin–Madison and Johns Hopkins University. HeLa cells display epithelial markers analyzed with techniques developed at Massachusetts Institute of Technology and have been used in assays refined at National Cancer Institute and Fred Hutchinson Cancer Center. Their robustness allowed use in organotypic models adopted by labs at Harvard Medical School and University College London.

Laboratory use and applications

HeLa cultures have been employed in a wide array of applications by investigators at institutions such as Rockefeller University, Salk Institute, Cleveland Clinic, and Princeton University: virology (including Poliovirus research at University of Pittsburgh), oncology studies at MD Anderson Cancer Center, pharmacology screening at Broad Institute, toxicology assays at EPA, and space biology experiments for NASA missions with collaborators like Jet Propulsion Laboratory. Techniques developed in HeLa include cell transfection methods refined at Cold Spring Harbor Laboratory, imaging protocols used at Max Planck Society facilities, and high-throughput sequencing approaches implemented at Wellcome Sanger Institute. HeLa’s utility extended to industrial and commercial entities including Merck, Pfizer, Roche, and Johnson & Johnson for drug discovery, and to public health programs coordinated with CDC and WHO.

Contamination and ethical issues

Widespread distribution of HeLa led to frequent contamination of other cell lines, a problem documented by researchers at ATCC and laboratories at University of Texas and University of California, Berkeley, prompting standards promoted by groups like ISCB and policy actions by NIH. Ethical controversies arose over consent, patient privacy, and commercial use involving news coverage by The Washington Post and legal examinations influenced by precedents such as cases at Supreme Court of the United States and debates in bioethics forums at Kennedy Institute of Ethics. The Lacks family’s negotiations with institutions including NIH and Johns Hopkins University highlighted issues of benefit sharing and data access, leading to policy discussions within organizations like National Academies of Sciences, Engineering, and Medicine and international dialogues at UNESCO.

Impact on research and medicine

HeLa cells transformed biomedical research across centers such as Harvard University, Yale University, University of Oxford, and Imperial College London by enabling reproducible in vitro experiments that supported breakthroughs including the development of the Polio vaccine and advances in cell cycle research tied to work honored by awards like the Nobel Prize in Physiology or Medicine. Their role influenced regulatory frameworks at agencies including FDA and NIH and informed best practices in cell culture, biobanking at organizations like ATCC and ethics oversight at Institutional Review Boards. The legacy of HeLa continues to affect collaborations between academic institutions such as Johns Hopkins University and communities represented by the Lacks family, shaping discussions at venues like TED and influencing curricula at universities including Columbia University and University of California, San Diego.

Category:Cell lines Category:Biomedical research